Biswadeep Das

5PUBLICATIONS
9CO-AUTHORS
PharmacogenomicsMedical molecular engineering of nucleic acids and proteinsToxicology (incl. clinical toxicology)Cellular nervous systemCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 20, 2025
Polypharmacy and anticholinergic burden scales in older adults: a cross-sectional study among psychiatric outpatients in a tertiary care hospital.

Manjunath Bidarolli, Biswadeep Das, Vikram Singh Rawat

|Feb 11, 2023
Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development.

Chayna Sarkar, Biswadeep Das, Vikram Singh Rawat

|Nov 29, 2021
Leading 20 drug-drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients.

Biswadeep Das, Saravana Kumar Ramasubbu, Akash Agnihotri

|Aug 27, 2021
Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease Models.

Biswadeep Das, Chayna Sarkar, Vikram Singh Rawat

|Dec 09, 2020
Quality of life and factors affecting it in adult cancer patients undergoing cancer chemotherapy in a tertiary care hospital.

Saravana Kumar Ramasubbu, Rajesh K Pasricha, Uttam K Nath

Pageof 1

Frequent Collaborators

3 joint publications

Vikram Singh Rawat

1 joint publications

Deepjyoti Kalita

1 joint publications

Sangeeta Deka

1 joint publications

Manjunath Bidarolli